TD Private Client Wealth’s CareDx CDNA Stock Holding History

TD Private Client Wealth’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2K	Hold	42	–	–	﹤0.01%	1446
2026 Q1	$729	Hold	42	–	–	﹤0.01%	1441
2025 Q4	$791	Hold	42	–	–	﹤0.01%	1412
2025 Q3	$611	Buy	+42	New	+$599	﹤0.01%	1441

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Private Client Wealth's CDNA Position: Q2 2026 in Review

TD Private Client Wealth held its CareDx (CDNA) position steady in Q2 2026 at 42 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

TD Private Client Wealth first reported a position in CDNA in Q3 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

TD Private Client Wealth held 42 shares of CareDx worth $1.2K as of Q2 2026.
TD Private Client Wealth left its CareDx share count unchanged in Q2 2026.
CareDx made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1446 holding.
TD Private Client Wealth first reported a position in CareDx in Q3 2025 and has held it in 4 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.